Clindamycin (Surgical Prophylaxis — Penicillin Allergy)
Brand names: Dalacin C
Clindamycin is a lincosamide antibiotic used here as an alternative agent for surgical antibiotic prophylaxis in patients with penicillin or cephalosporin allergy, providing cover against staphylococci, streptococci, and anaerobes.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It inhibits bacterial protein synthesis by binding the 50S ribosomal subunit, acting in a bacteriostatic manner.
Prescribing in practice
- It is strongly associated with Clostridioides difficile infection, so use should be reserved, kept short, and stopped promptly if significant diarrhoea develops.
- When given intravenously it should be infused slowly rather than as a rapid bolus to avoid cardiovascular reactions.
- It is a useful choice in beta-lactam allergy but does not provide the Gram-negative cover that some procedures require, so additional cover may be needed.
Monitoring
Monitor for diarrhoea and signs of Clostridioides difficile infection, clinical response, and infusion-related effects with intravenous use.
Counselling the patient
- Report any diarrhoea, especially if severe, watery, or with blood, even after finishing the antibiotic.
- This may be given because you are allergic to penicillin-type antibiotics.
- Tell staff about all your allergies and any previous bowel infections.
Evidence & guidelines
Clindamycin is an established option for surgical prophylaxis in beta-lactam allergy, with its Clostridioides difficile risk well documented in stewardship guidance.
Reference: WHO SSI Guidelines 2016; PHE Penicillin Allergy Guidance; SIGN 104; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- POSSUM Score for Surgical Morbidity and Mortality · Perioperative Risk
- SORT (Surgical Outcome Risk Tool) · Perioperative Risk
- ASA Physical Status Classification · Perioperative Risk
- Caprini Score for VTE Risk (2005) · VTE Risk
- EuroSCORE II · Surgical Risk
- Thakar Score for AKI after Cardiac Surgery · Surgical Risk
- Major Trauma — Primary Survey (ATLS) · ATLS 10th Edition; JRCALC; NICE NG39
- Major Haemorrhage / Massive Transfusion · BCSH; RCOA; RCEM; RCS — BCSH Guidelines
- Burns — TBSA Estimation & Fluid Resuscitation · British Burn Association; EMSB; RCEM 2024
- Lower Gastrointestinal Bleed · NICE; BSG; ACPGBI — Commissioning Guide
- Acute Pancreatitis · NICE; IAP/APA; ACPGBI — CG104
- Hypertrophic Pyloric Stenosis · BAPS / RCPCH